Home / Market News / $NEOG
benzinga Corporate Catalyst Impact 95/100 ● negative

Why is Neogen Stock Trading Lower on Tuesday?

Sep 29, 2026, 6:43 PM UTC · Primary ticker $NEOG

The FDA issued a formal warning letter to Neogen Corp's CEO regarding severe microbiological contamination in its HYCOAT product, linked to widespread horse fatalities. This significant regulatory action and product defect have led to a sharp decline in Neogen's stock price.

Neogen Corp received a formal warning letter from the FDA, citing severe microbiological contamination in its HYCOAT product, which has been directly linked to the largest number of equine fatalities ever associated with a product quality defect in a sterile FDA-regulated veterinary medical product. This is a major negative catalyst for the company, as it highlights critical failures in manufacturing and quality control, leading to product adulteration and misbranding. The immediate impact is a significant drop in NEOG's stock price, reflecting investor concern over potential legal action, regulatory fines, reputational damage, and a loss of market trust. In the short term, the company faces the challenge of responding to the FDA within 15 working days and implementing comprehensive corrective actions. Long-term implications could include increased regulatory scrutiny, potential lawsuits, and a lasting hit to its brand image in the veterinary pharmaceutical market, posing a significant risk for traders.

$NEOG negative FDA warning letter, product contamination, horse deaths
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.